Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester

Globally, COVID-19 vaccines are currently being used to prevent transmission and to reduce morbidity and death associated with SARS-CoV-2 infection. Current research reveals that vaccines such as BNT162b2 and Ad26.COV2.S are highly immunogenic and have high short-term effectiveness for most of the k...

Descripción completa

Detalles Bibliográficos
Autores principales: Citu, Ioana Mihaela, Citu, Cosmin, Gorun, Florin, Sas, Ioan, Tomescu, Larisa, Neamtu, Radu, Motoc, Andrei, Gorun, Oana Maria, Burlea, Bogdan, Bratosin, Felix, Malita, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878278/
https://www.ncbi.nlm.nih.gov/pubmed/35215900
http://dx.doi.org/10.3390/v14020307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878278/
https://www.ncbi.nlm.nih.gov/pubmed/35215900
http://dx.doi.org/10.3390/v14020307

Ejemplares similares